clonoSEQ for minimal residual disease assessment in multiple myeloma, acute lymphoblastic leukaemia and chronic lymphocytic leukaemia (MIB278)Product type:AdviceProgramme:Medtech innovation briefingPublished: 30 November 2021
MMprofiler for prognostic risk classification in multiple myeloma (MIB270)Product type:AdviceProgramme:Medtech innovation briefingPublished: 10 August 2021
The Arrow OnControl powered bone marrow biopsy system for bone marrow aspiration and biopsy (MIB19)Product type:AdviceProgramme:Medtech innovation briefingPublished: 12 February 2015